Plan sponsors, insurers push for generic drugs

‘No substitution’ notes from doctors more common

In an effort to curtail rising health plan costs, employers and insurance companies are pushing for generic drug substitution among employees, rejecting more claims for brand name drugs. And it’s about time, according to Michael Law, an assistant professor in the School of Population and Public Health at the University of British Columbia in Vancouver.

To read the full story, login below.

Not a subscriber?

Start your subscription today!